The effect of clinical characteristics on the lecithin/sphingomyelin ratio and lamellar body count: A cross-sectional study

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 14, Issue 6, 2003, Pages 373-382

  Wijnberger, L D E ^a   De Kleine, M ^a   Voorbij, H A M ^a   Arabin, B ^b   Van De Leur, J J C M ^b   Bruinse, H W ^a   Visser, G H A ^a   Bossuyt, P M M ^c   Mol, B W J ^a,c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ISALA HOSPITAL   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Amniotic fluid; Diabetes; Gestational age; Glucocorticoids; Lamellar body count; Lecithin sphingomyelin ratio

Indexed keywords

GLUCOCORTICOID; PHOSPHATIDYLCHOLINE; SPHINGOMYELIN;

AMNION FLUID ANALYSIS; CORTICOSTEROID THERAPY; FEMALE; FETUS; FETUS LUNG MATURITY; GESTATIONAL AGE; HUMAN; HYDRAMNIOS; INTRAUTERINE GROWTH RETARDATION; LAMELLAR BODY COUNT; LECITHIN SPHINGOMYELIN RATIO; MAJOR CLINICAL STUDY; MATERNAL DIABETES MELLITUS; NEWBORN; OLIGOHYDRAMNIOS; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; REVIEW;

AMNIOTIC FLUID; CROSS-SECTIONAL STUDIES; FEMALE; FETAL ORGAN MATURITY; GESTATIONAL AGE; HOSPITALS, UNIVERSITY; HUMANS; INFANT, NEWBORN; LUNG; MEDICAL RECORDS; NETHERLANDS; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLGLYCEROLS; PREDICTIVE VALUE OF TESTS; PREGNANCY; PRENATAL DIAGNOSIS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RETROSPECTIVE STUDIES; SPHINGOMYELINS;

EID: 0346880091     PISSN: 14767058     EISSN: None     Source Type: Journal    
DOI: 10.1080/14767050412331312210     Document Type: Review

References (45)

1. Gluck L, Kulovich MV. Lecithin/sphingomyelin ratios in amniotic fluid in normal and abnormal pregnancy. Am J Obstet Gynecol 1973;15:539-46
2. Dubin SB. Assessment of fetal lung maturity. Practice parameter. Am J Clin Pathol 1998;110:723-32
3. Neerhof MG, Dohnal JC, Ashwood ER, et al. Lamellar body counts: a consensus on protocol. Obstet Gynecol 2001;97: 318-20
4. Neerhof MG, Haney EI, Silver RK, et al. Lamellar body counts compared with traditional phospholipid analysis as an assay for evaluating fetal lung maturity. Obstet Gynecol 2001;97: 305-9
5. Nakamura J, Roux JF, Brown EG, et al. Total lipids and the lecithin-sphingomyelin ratio of amniotic fluid: an antenatal test of lung immaturity? Am J Obstet Gynecol 1972;113:363-6
6. Nugent CE, Ayers JWT, Menon KMJ. Comparison of amniotic fluid disaturated phosphatidylcholine and the lecithin-sphingomyelin ratio in the prediction of fetal lung maturity. Obstet Gynecol 1986;68:541-5
7. Spellacy WN, Buhi WC. Amniotic fluid lecithin-sphingomyelin ratio as an index of fetal maturity. Obstet Gynecol 1972;39:852-60
8. Herbert WNP, Tyson J, Jimenez JM. Severity of respiratory distress syndrome with low lecithin:sphingomyelin ratio. Obstet Gynecol 1981;57:426-30
9. Simon NV, Williams GH, Fairbrother PF, et al. Prediction of fetal lung maturity by amniotic fluid fluorescence polarization, L:S ratio, and phosphatidyl glycerol. Obstet Gynecol 1981;57: 295-300
10. White CA, Musiala TS, Witte DL. Amniotic fluid lecithin-sphingomyelin ratio as a measure of fetal pulmonary maturity. Iowa Med Soc 1972;62:279-84
11. Geyer H, Klosa W. Amniotic fluid tests for fetal lung maturity [author's transl]. Fruchtwasser-Untersuchungen zur Bestimmung der fetalen Lungenreife. Z Geburtshilfe Perinatol 1978;182:205-11
12. Merola JCL, Johnson LM, Bolognese RJ, et al. Determination of fetal pulmonary maturity by amniotic fluid lecithin-sphingomyelin ratio and rapid shake test. Am J Obstet Gynecol 1974;119:243-52
13. Kuhnert PM, Erhard P, Kuhnert BR, et al. A modified lecithin/ sphingomyelin ratio test for fetal maturity. Am J Obstet Gynecol 1979;135:331-6
14. Greenspoon JS, Rosen DJD, Roll K, et al. Evaluation of lamellar body number density as the initial assessment in a fetal lung maturity test cascade. J Reprod Med 1995;40: 260-6
15. Fakhoury G, Daikoku NH, Benser J, et al. Lamellar body concentrations and the prediction of fetal pulmonary maturity. Am J Obstet Gynecol 1994;170:72-6
16. Arias F, Pineda J, Johnson LW. Changes in human amniotic fluid lecithin/sphingomyelin ratio and dipalmitoyl lecithin associated with maternal betamethasone therapy. Am J Obstet Gynecol 1979;133:894-8
17. Kattner E, Metze B, Waiss E, et al. Accelerated lung maturation following maternal steroid treatment in infants born before 30 weeks gestation. J Perinat Med 1992;20:449-57
18. Ekelund L, Arvidson G, Ohrlander S, et al. Changes in amniotic fluid phospholipids on treatment with glucocorticoids to prevent respiratory distress syndrome. Acta Obstet Gynecol Scand 1976;55:413-17
19. Farrell PM, Engle MJ, Zachman RD, et al. Amniotic fluid phospholipids after maternal administration of dexamethasone. Am J Obstet Gynecol 1983;145:484-90
20. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972;50: 515-25
21. Robert MF, Neff RK, Hubbell JP, et al. Association between maternal diabetes and the respiratory-distress syndrome in the newborn. N Engl J Med 1976;294:357-60
22. Whitfield CR, Sproule WB, Brudenell M. The amniotic fluid lecithin:sphingomyelin area ratio (LSAR) in pregnancies complicated by diabetes. J Obstet Gynaecol Br Commonw 1973;80:918-22
23. Farrell PM. Indices of fetal maturation in diabetic pregnancy. Lancet 1976;1:596
24. Dahlenburg GW, Martin FI, Jeffrey PE, et al. Amniotic fluid lecithin/sphingomyelin ratio in pregnancy complicated by diabetes. Br J Obstet Gynaecol 1977;84:294-9
25. Piazze JJ, Anceschi MM, Maranghi L, et al. Fetal lung maturity in pregnancies complicated by insulin-dependent and gestational diabetes: a matched cohort study. Eur J Obstet Gynecol Reprod Biol 1999;83:145-50
26. Kulovich MV, Gluck L. The lung profile. II. Complicated pregnancy. Am J Obstet Gynecol 1979;135:64-70
27. Tabsh KMA, Brinkman CR 3rd, Bashore RA. Lecithin: sphingomyelin ratio in pregnancies complicated by insulin-dependent diabetes mellitus. Obstet Gynecol 1982;59:353-8
28. Moore TR. A comparison of amniotic fluid fetal pulmonary phospholipids in normal and diabetic pregnancy. Am J Obstet Gynecol 2002;186:641-50
29. Curet LB, Tsao FH, Zachman RD, et al. Phosphatidylglycerol, lecithin/sphingomyelin ratio and respiratory distress syndrome in diabetic and non-diabetic pregnancies. Int J Gynaecol Obstet 1989;30:105-8
30. Cunningham MD, McKean HE, Gillispie DH, et al. Improved prediction of fetal lung maturity in diabetic pregnancies: a comparison of chromatographic methods. Am J Obstet Gynecol 1982;142:197-204
31. Bernstein IM, Horbar JD, Badger GJ, et al. Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction. The Vermont Oxford Network. Am J Obstet Gynecol 2000;182:198-206
32. Ley D, Wide-Swensson D, Lindroth M, et al. Respiratory distress syndrome in infants with impaired intrauterine growth. Acta Paediatr 1997;86:1090-6
33. Tyson JE, Kennedy K, Broyles S, et al. The small for gestational age infant: accelerated or delayed pulmonary maturation? Increased or decreased survival? Pediatrics 1995;95:534-8
34. Lindback T. Amniotic fluid lecithin concentrations in pregnancies complicated by hypertensive disorders and intrauterine growth retardation. Acta Obstet Gynecol Scand 1976;55:355-60
35. Gross TL, Sokol RJ, Wilson MV, et al. Amniotic fluid phosphatidylglycerol: a potentially useful predictor of intrauterine growth retardation. Am J Obstet Gynecol 1998;140:277-81
36. Gunston KD, Davey DA. Growth-retarded fetuses and pulmonary maturity. S Afr Med J 1978;54:493-4
37. Dewhurst CJ, Dunham AM, Harvey DR, et al. Prediction of respiratory-distress syndrome by estimation of surfactant in the amniotic fluid. Lancet 1973;1:1475-7
38. Skjaeraasen J. Amniotic fluid phospholipid concentrations in pregnancies with pre-eclampsia and/or intrauterine growth-retardation of the fetus. Acta Obstet Gynecol Scand 1979;58: 191-5
39. Nelson GH, Nelson SJ. Theoretical effects of amniotic fluid volume changes on surfactant concentration measurements. Am J Obstet Gynecol 1985;152:870-8
40. Piazze JJ, Maranghi L, Cosmi EV, et al. The effect of polyhydramnios and oligohydramnios on fetal lung maturity indexes. Am J Perinatol 1998;15:249-52
41. Giedion A, Haefliger H, Dangel P. Acute pulmonary X-ray changes in hyaline membrane disease treated with artificial ventilation and positive end-expiratory pressure (PEP). Pediatr Radiol 1973;1:145-52
42. Bourbon JR, Farrell PM. Fetal lung development in the diabetic pregnancy. Pediatr Res 1985;19:253-67
43. Bolt RJ, Weissenbruch MM, Lafeber HN, et al. Glucocorticoids and lung development in the fetus and preterm infant. Pediatr Pulmonol 2001;32:76-91
44. Lauria MR, Dombrowski MP, Delaney-Black V, et al. Lung maturity tests. Relation to source, clarity, gestational age and neonatal outcome. J Reprod Med 1996;41:685-91
45. Hunink MG, Richardson DK, Doubilet PM, et al. Testing for fetal pulmonary maturity: ROC analysis involving covariates, verification bias, and combination testing. Med Decis Making 1990;10:201-11